融券方面，汉邦科技8月26日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量0.00股，融券余额0.00元。 资料显示，江苏汉邦科技股份有限公司位于江苏省淮安经济技术开发区新竹路10号,淮安经济技术开发 区集贤路1-9号，成立日期1998年10月28日，上市日期2025年5月16日，公司主营业务涉及为制药、生命 科学等领域提供专业的分离纯化装备、耗材、应用技术服务及相关的技术解决方案。 截至6月30日，汉邦科技股东户数9372.00，较上期减少48.43%；人均流通股1764股，较上期增加 93.92%。2025年1月-6月，汉邦科技实现营业收入3.49亿元，同比增长5.99%；归母净利润2779.76万元， 同比减少26.24%。 8月26日，汉邦科技涨1.63%，成交额1.35亿元。两融数据显示，当日汉邦科技获融资买入额2154.27万 元，融资偿还1137.76万元，融资净买入1016.51万元。截至8月26日，汉邦科技融资融券余额合计 8638.29万元。 融资方面，汉邦科技当日融资买入2154.27万元。当前融资余额8638.29万元，占流通市值的9.64%。 ...

Core Viewpoint - C Hanbang (688755) experienced a significant increase of 102.46% on its first trading day, with a turnover rate of 75.65% and a transaction volume of 609 million yuan [2]. Group 1: Company Overview - C Hanbang is a high-tech enterprise focused on chromatography technology, integrating research and development, production, and sales. The company primarily provides professional separation and purification equipment, consumables, application technology services, and related technical solutions for the pharmaceutical and life sciences sectors [2]. Group 2: Market Performance - On its debut, C Hanbang's financing buy-in amounted to 49.50 million yuan, accounting for 8.13% of the total trading volume. The latest financing balance stands at 41.76 million yuan, representing 5.48% of the circulating market value [2]. - The stock attracted a net inflow of 210 million yuan from major funds on its first day, with large orders contributing a net inflow of 81.52 million yuan and big orders contributing 129 million yuan [2].

Company Overview - N Hanbang has been listed today with an opening price of 49.00 yuan, representing an increase of 115.20% from its issue price [2] - The company focuses on chromatography technology, integrating research and development, production, and sales, primarily serving the pharmaceutical and life sciences sectors with specialized separation and purification equipment, consumables, application technology services, and related technical solutions [2] Financial Highlights - The total number of shares issued by the company is 22 million, with an online issuance of 7.04 million shares at an issue price of 22.77 yuan per share [2] - The issue price corresponds to a price-to-earnings (P/E) ratio of 26.35, compared to the industry average P/E ratio of 28.04 [2] - The total funds raised from the initial public offering (IPO) amount to 501 million yuan, which will be used for working capital, the construction of a chromatography separation equipment R&D center, and the production projects for laboratory chromatography separation and purification instruments [2] Recent IPO Performance - N Hanbang's first-day performance is notable, with a significant increase of 115.20% [2] - Other recent IPOs on the same day include N Zairun, which saw a rise of 98.12%, and Tian Gong Co., which experienced a dramatic increase of 458.63% [3]

Company Overview - Hanbang Technology is a high-tech enterprise focused on chromatography technology, providing professional separation and purification equipment, consumables, application technology services, and related technical solutions primarily for the pharmaceutical and life sciences sectors [1]. IPO Details - The company is set to launch its public offering with a total share capital of 66 million shares, of which 22 million shares will be publicly issued, representing 25% of the post-issue total share capital [1]. - The issue price is set at 22.77 yuan per share, with an earnings per share (EPS) ratio of 26.35 times, compared to the industry average of 28.04 times [1]. - The maximum subscription limit for a single account is 5,000 shares, requiring a minimum market value of 50,000 yuan in the Shanghai market for top-tier subscriptions [1]. Fundraising Allocation - The funds raised will be allocated to several projects, including: - Production project for 1,000 units of liquid chromatography series separation equipment (193.03 million yuan) - Construction of a chromatography separation equipment R&D center (271.10 million yuan) - Production project for 2,000 units of laboratory chromatography separation and purification instruments (224.76 million yuan) - Supplementing working capital (291.11 million yuan) [1]. Financial Performance - Key financial indicators for Hanbang Technology include: - Total assets for 2024 are projected at 1.32 billion yuan, a decrease from 1.35 billion yuan in 2023 and 1.40 billion yuan in 2022 [1]. - Net assets have increased to 739.63 million yuan in 2024 from 638.37 million yuan in 2023 and 566.92 million yuan in 2022 [1]. - Operating revenue is expected to reach 690.88 million yuan in 2024, up from 619.01 million yuan in 2023 and 481.79 million yuan in 2022 [1]. - Net profit attributable to shareholders is projected at 79.34 million yuan for 2024, compared to 51.50 million yuan in 2023 and 38.56 million yuan in 2022 [1]. - Basic and diluted earnings per share are both expected to be 1.20 yuan in 2024, up from 0.78 yuan in 2023 and 0.62 yuan in 2022 [1]. - The weighted average return on equity is projected at 11.51% for 2024, an increase from 8.55% in 2023 and 9.86% in 2022 [1]. - Net cash flow from operating activities is expected to be 129.88 million yuan in 2024, compared to 113.33 million yuan in 2023 and 19.84 million yuan in 2022 [1]. - R&D investment is projected at 41.85 million yuan in 2024, representing 6.06% of operating revenue, consistent with previous years [1].